HEPARIN-ASSOCIATED THROMBOCYTOPENIA TYPE-II IN A PATIENT WITH END-STAGE RENAL-DISEASE - SUCCESSFUL ANTICOAGULATION WITH THE LOW-MOLECULAR-WEIGHT HEPARINOID ORG-10172 DURING HEMODIALYSIS

被引：0
|
作者：
GREINACHER, A
PHILIPPEN, KH
KEMKESMATTHES, B
MOCKL, M
MUELLERECKHARDT, C
SCHAEFER, K
机构：
[1] ST JOSEPH HOSP,DEPT MED 2,BERLIN,GERMANY
[2] UNIV GIESSEN,DEPT MED,W-6300 GIESSEN,GERMANY
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1993年 / 8卷 / 10期
关键词：
DIALYSIS; EXTRACORPOREAL CIRCULATION; HEPARIN; HEPARIN-ASSOCIATED THROMBOCYTOPENIA; HEPARINOID; ORG-10172; PLATELETS; THROMBOCYTOPENIA;
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：1176 / 1177
页数：2
相关论文
共 9 条
  • [1] ANTICOAGULANT WITH THE LOW-MOLECULAR-WEIGHT HEPARINOID ORG-10172 (ORGARAN(R)) DURING HEMODIALYSIS IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA
    MAHUL, P
    RAYNAUD, J
    FAVRE, JP
    JOSPE, R
    DECOUSUS, H
    AUBOYER, C
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1995, 14 (01): : 29 - 32
  • [2] HEPARIN-INDUCED THROMBOCYTOPENIA - INVITRO STUDIES WITH LOW-MOLECULAR-WEIGHT HEPARINOID, ORG-10172
    CHONG, BH
    ISMAIL, F
    CADE, J
    GALLUS, AS
    GORDON, S
    CHESTERMAN, CN
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 308 - 308
  • [3] HEPARIN-ASSOCIATED THROMBOCYTOPENIA - SUCCESSFUL THERAPY WITH THE HEPARINOID ORG-10172 IN A PATIENT SHOWING CROSS-REACTION TO LMW HEPARINS
    GREINACHER, A
    DROST, W
    MICHELS, I
    LEITL, J
    GOTTSMANN, M
    KOHL, HJ
    GLASER, M
    MUELLERECKHARDT, C
    ANNALS OF HEMATOLOGY, 1992, 64 (01) : 40 - 42
  • [4] HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II - PLATELET-AGGREGATION STUDIES WITH LOW-MOLECULAR-WEIGHT HEPARINS AND HEPARINOID ORG 10172
    HARBRECHT, UM
    UNKRIG, CJ
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1302 - 1302
  • [5] PLATELET-AGGREGATION IN RESPONSE TO 4 LOW-MOLECULAR-WEIGHT HEPARINS AND THE HEPARINOID ORG-10172 IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
    KEELING, DM
    RICHARDS, EM
    BAGLIN, TP
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) : 425 - 426
  • [6] Low-molecular-weight heparin administration in patients with end-stage renal disease - A comment
    Lile, J
    PHARMACOTHERAPY, 2001, 21 (08): : 1017 - 1017
  • [7] Low-molecular-weight heparin administration in patients with end-stage renal disease - Author's reply
    Brophy, DF
    Wazny, LD
    Gehr, TWB
    Comstock, TJ
    Venitz, J
    PHARMACOTHERAPY, 2001, 21 (08): : 1017 - 1019
  • [8] Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis
    Hainer, JW
    Sherrard, DJ
    Swan, SK
    Barrett, JS
    Assaid, CA
    Fossler, MJ
    Cox, DS
    Williams, RM
    Pittenger, AL
    Stephenson, CA
    Hua, TA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (03) : 531 - 538
  • [9] Can Low-Molecular-Weight Heparin Be Safely Used as Prophylaxis Against Venous Thromboembolism in Critically Ill Patients with End-Stage Renal Disease? A Subgroup Analysis of the Protect Trial
    Douketis, James
    Pai, Menaka
    Walsh, Michael
    Heels-Ansdell, Diane
    Zytaruk, Nicole
    Cook, Deborah
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S199 - S200
1